[June29]Kstock Today Summary: KOSDAQ Soars +8.13% Triggering Buy Sidecar!

Kstock Today Summary: Massive Capital Inflows into Construction, Bio, and Battery Sectors on 800tn KRW Regional Semi-Investment Rumors

Hello, global investors. Today, June 29, 2026(Mon), marked an absolute historic and unforgettable session in the Korean equity market[cite: 5]. Completely shrugging off last week’s aggressive mid-year rebalancing and institutional basket dumping, the tech-heavy KOSDAQ market witnessed an extraordinary +8.13% explosion, closing at 920.57[cite: 5]. The massive surge in retail and short-covering inflows was so powerful that it officially triggered the intraday “Buy Sidecar” cooling mechanism to temporarily halt program trading[cite: 5]. Meanwhile, the KOSPI index took a healthy brief breather, consolidating slightly as mega-cap chip names stabilized after previous volatility[cite: 5].

📊 K-Stock Market Snapshot (June 29, 2026)
• KOSPI Index: 8,394.65 (-0.20%)[cite: 5]
• KOSDAQ Index: 920.57 (+8.13%)[cite: 5]
• Core Market Drivers: Imminent official announcement regarding the government’s 800 trillion KRW Southwest (Honam) regional semiconductor mega-investment, combined with aggressive short-covering flows in Bio and Battery sectors catalyzed by the strategic deployment of the National Growth Fund[cite: 5].

The stark decoupling between KOSPI and KOSDAQ highlighted a monumental sector rotation[cite: 5]. While index heavyweights kept the KOSPI flat, capital aggressively rotated into high-beta tech plays, secondary battery chains, and regional infrastructure developers[cite: 5]. Below is your comprehensive, deep-dive breakdown of today’s key market drivers and standout corporate performers[cite: 5].

---

1. “800 Trillion KRW Southwest Megadeal” Sparks Historic Upper-Limit Rally in Construction Stocks

Speculation that Samsung Electronics and SK Hynix are finalized to invest a staggering 800 trillion KRW to construct four cutting-edge semiconductor fabrication plants (fabs) in the Southwest region completely dominated domestic market sentiment today[cite: 5]. To successfully operate these mega-scale campuses, a vast array of auxiliary facilities—including power sub-stations, industrial water infrastructure, wastewater treatment systems, and residential dormitories—must be built concurrently[cite: 5]. This massive expansion of the infrastructure order pipeline directly translated into an institutional buying frenzy across civil engineering and regional building sectors[cite: 5].

• Mid-Tier & Regional Builders Hit Daily Limit: Kumho Construction (+29.86%), Namhwa Topcon (+29.94%), and Namhwa Industry (+30.00%) all locked directly at their maximum daily upper limits due to their strong geographic ties and historical dominance in the Honam construction landscape[cite: 5]. Kyeryong Construction (+19.02%) also experienced vertical price action[cite: 5].
• Large-Scale Engineering Corporations Advance: Industrial plant giants such as Samsung E&A (+14.96%) and Hyundai Engineering & Construction (+12.39%) posted explosive double-digit gains[cite: 5]. Analysts noted that the massive scope of the industrial utility networks required for a mega-cluster guarantees a multi-year 수주 (order backlog) expansion for prime contractors[cite: 5].

2. K-Bio Triggers Market-Wide “Buy Sidecar” Fueled by 30tn KRW Global Tech-License Potential

Previously severely sidelined and beaten down due to an unfavorable global interest rate environment and hyper-centralization of liquidity into hardware tech, the K-Bio and healthcare sector staged a brilliant, breathtaking resurrection[cite: 5]. Sentiment turned sharply positive as the newly established, policy-driven National Growth Fund actively commenced its multi-trillion won capital deployments, reminding global investors of the massive fundamental value hidden within Korean clinical-stage pipelines[cite: 5].

• Leading Bio and Target-R&D Gainers: High-profile clinical innovators heavily led KOSDAQ’s vertical surge[cite: 5]. Standouts included Orum Therapeutics (+26.17%), OliX Pharmaceuticals (+24.22%), ABL Bio (+20.18%), and Peptron (+19.64%)[cite: 5]. Short-sellers were forced to aggressively cover their positions as heavy institutional buying volume flooded the order books[cite: 5].
• Hanall Biopharma (+19.38%) Gains Global Spotlight: The company’s premier autoimmune candidate, ‘IMVT-1402’, received massive validation after global market intelligence firm Evaluate highlighted the asset’s net present value at a jaw-dropping $17 billion (approx. 26 trillion KRW)[cite: 5]. With a projected 2032 annual revenue of $5.1 billion, the pipeline is officially being recognized by global big pharma as a prospective “Best-in-Class” therapeutic solution[cite: 5].

3. Global EV Demand Bottoms Out: Powerful Rebound in Battery & ESS Value Chains

The long-awaited cyclical bottoming of the secondary battery sector was confirmed today by spectacular macro data[cite: 5]. According to the European Automobile Manufacturers’ Association (ACEA), European electric vehicle sales for May drastically leaped by 39.1% year-on-year, proving that the EV market is structurally moving past its temporary slowdown[cite: 5]. Furthermore, global tech infrastructure reports increasingly pointed to Energy Storage Systems (ESS) as the absolute maximum bottleneck in AI data center expansion, creating a high-margin secondary growth engine for battery material providers[cite: 5].

• Material & Cell Giants Explode: Industry bellwether Enchem (+27.71%) nearly touched its daily ceiling on massive institutional volume[cite: 5]. It was closely followed by spectacular rallies from EcoPro (+23.69%), LG Energy Solution (+20.81%), L&F (+18.20%), and POSCO Future M (+16.81%)[cite: 5]. The broad-based nature of the rally signals strong sector-wide conviction regarding a Q3 operational turnaround[cite: 5].

4. Front-End Semiconductor Equipment & High-Growth ASIC Standouts

While passive index funds mechanically trimmed mega-cap cell suppliers, active smart money heavily accumulated mission-critical supply chain players specializing in high-bandwidth memory (HBM) packaging and specialized application-specific integrated circuit (ASIC) design services[cite: 5].

• Justek (+40.24%) Records Astronomical Gains: Investors aggressively bid up the stock due to its highly specialized, proprietary ultra-precision motion stage systems[cite: 5]. These motion systems are essential components integrated directly into advanced HBM laser-cutting, thermal annealing, and high-speed die-bonding equipment manufactured by leading suppliers for final deployment in Samsung and SK Hynix production lines[cite: 5].
• Asicland (+29.81%) Locks Near Limit on Massive Deal: As the sole TSMC Value Chain Alliance (VCA) partner in Korea, Asicland skyrocketed after officially announcing a major **31.9 billion KRW contract** with SK Hynix[cite: 5]. The deal tasks Asicland with the architectural design, verification, and tape-out of next-generation enterprise SSD (eSSD) controllers utilizing TSMC’s ultra-advanced advanced foundry nodes[cite: 5].

---

🎯 Long-Term Market Outlook & Strategic Investor Takeaways

Today’s historic KOSDAQ session clearly demonstrates that the underlying fundamental health of the Korean tech ecosystem is incredibly robust[cite: 5]. The short-term index distortions caused by mechanical mid-year rebalancing have paved the way for a powerful, catalyst-driven stock-picking market[cite: 5]. Moving forward into July, active portfolio outperformance will be heavily defined by tracking specific regulatory approvals, corporate M&A timelines, and structural tailwinds stemming from the national mega-projects[cite: 5].

💡 Verified Source & Editorial Coverage Links:

• [Breaking News] Government & Tech Giants Plan Epic 800 Trillion KRW Semiconductor Mega Cluster & 4 Fabs in Southwest Region[cite: 5]
• [Supply Deal] Asicland Secures Landmark 31.9bn KRW Next-Generation Enterprise eSSD Controller ASIC Design Contract with SK Hynix via TSMC Nodes[cite: 5]

*Disclaimer: This market intelligence report is prepared strictly for educational and informational purposes based on the “2026.06.29.(월) Signal Evening.pdf” and does not constitute financial or professional investment advice[cite: 5]. The selection and execution of all equity trades remain the sole responsibility of the individual investor.*